Jiangsu Vcare PharmaTech Secures RMB200 Million in Series C+ Financing
Jiangsu Vcare PharmaTech Co., Ltd., a China – based high – tech pharmaceutical company, has...
CRO / CMO / CDMO
NAMSA to Acquire WuXi AppTec’s US Medical Device Testing Business
US-based medical device contract research organization (CRO) NAMSA is set to acquire the medical device...
WuXi Biologics to Sell Irish Vaccine Assets to MSD for USD 500 Million
China-based Contract Research, Development and Manufacturing Organization (CRDMO) WuXi Biologics (HKG: 2269) is poised to...
Cygenta Partners with IZVARINO Pharma for Comprehensive CDMO Services
Cygenta, a cell and gene therapy (CGT) focused Contract Development and Manufacturing Organization (CDMO) based...
WuXi Biologics Partners with Sino Biopharmaceutical for First-in-Class Monoclonal Antibody Development
China-based Contract Research, Development, and Manufacturing Organization (CRDMO) WuXi Biologics (HKG: 2269) has announced a...
uBriGene Secures RMB 200 Million in Pre-Series D Financing to Expand ATMPs CDMO Services
China-based uBriGene, a contract development and manufacturing organization (CDMO) focused on advanced therapy medicinal products...
WuXi AppTec to Divest WuXi Advanced Therapies and Oxford Genetics to Altaris LLC
China-based Contract Development and Manufacturing Organization (CDMO) WuXi AppTec Co., Ltd (SHA: 603259) has announced...
Sumitomo Pharma Expands Collaboration with Shanghai Pharmaceuticals for Prescription Drug Co-Marketing
Japan-based Sumitomo Pharma Co., Ltd (TYO: 4506) has announced an expanded Contract Sales Organization (CSO)...
Quantum Hi-Tech (ChemPartner) Plans to Raise Over RMB 930 Million in Private Placement
Quantum Hi-Tech (China) Biotechnology Co., Ltd, known as ChemPartner (SHE: 300149), is poised to raise...
Mabwell Bioscience Plans Secondary Listing in Hong Kong, Secures Funding for Bone Health Project
Mabwell (Shanghai) Bioscience Co., Ltd. (SHA: 688062) is set to make a secondary listing on...
VIVA Biotech Expands Global Footprint with New Boston Branch
China-based Contract Research Organization (CRO) VIVA Biotech (HKG: 1873) has announced the inauguration of its...
Porton Pharma Solutions and OD Kingsley Life Sciences Form Partnership for Bio Conjugated Drug Development
China-based Contract Development and Manufacturing Organization (CDMO) Porton Pharma Solutions (SHE: 300363) has announced a...
Novo Holdings’ Acquisition of Catalent Gets EU Nod, Paving Way for Novo Nordisk Expansion
The acquisition of contract development and manufacturing organization (CDMO) Catalent (NYSE: CTLT) by Novo Holdings...
Medtide Inc. Submits Second IPO Application to Hong Kong Stock Exchange
Medtide Inc., a Contract Research, Development, and Manufacturing Organization (CRDMO) specializing in polypeptides and based...
Cambrex Partners with Eli Lilly to Enhance Clinical Development for Biotech Collaborators
US-based contract development and manufacturing organization (CDMO) Cambrex has reached an agreement with Eli Lilly...
CORXEL Partners with Apeloa Pharmaceutical for CDMO Services Expansion
China-based contract development and manufacturing organization (CDMO) Apeloa Pharmaceutical Co., Ltd (SHE: 000739) has announced...
WuXi Biologics Expands Sterile Filling Capabilities in Germany with New Line
China’s Contract Research, Development, and Manufacturing Organization (CRDMO) WuXi Biologics (HKG: 2269) has announced plans...
Shanghai Duoning Biotechnology Partners with Branca Bunús for Transfection Reagents Innovation
Shanghai Duoning Biotechnology Co., Ltd, a prominent biopharmaceutical company in China, has entered into a...
WuXi AppTec Reports Q3 2024 Revenues of RMB 10.46 Billion Amid Biosecure Act Challenges
WuXi AppTec Co., Ltd (SHA: 603259), the China-based Contract Development and Manufacturing Organization (CDMO) facing...
Tianjin Municipality Unveils Plan to Boost Synthetic Biology and Biomanufacturing Innovation
The People’s Government of Tianjin Municipality has unveiled two significant implementation plans to bolster the...